These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 27785771)

  • 1. Pharmacoeconomic Considerations in Treating Actinic Keratosis: An Update.
    Vale SM; Hill D; Feldman SR
    Pharmacoeconomics; 2017 Feb; 35(2):177-190. PubMed ID: 27785771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacoeconomic considerations in treating actinic keratosis.
    Neidecker MV; Davis-Ajami ML; Balkrishnan R; Feldman SR
    Pharmacoeconomics; 2009; 27(6):451-64. PubMed ID: 19640009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A trial-based cost-effectiveness analysis of topical 5-fluorouracil vs. imiquimod vs. ingenol mebutate vs. methyl aminolaevulinate conventional photodynamic therapy for the treatment of actinic keratosis in the head and neck area performed in the Netherlands.
    Jansen MHE; Kessels JPHM; Merks I; Nelemans PJ; Kelleners-Smeets NWJ; Mosterd K; Essers BAB
    Br J Dermatol; 2020 Oct; 183(4):738-744. PubMed ID: 31961446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of facial actinic keratoses with aminolevulinic acid photodynamic therapy (ALA-PDT) or ingenol mebutate 0.015% gel with and without prior treatment with ALA-PDT.
    Berman B; Nestor MS; Newburger J; Park H; Swenson N
    J Drugs Dermatol; 2014 Nov; 13(11):1353-6. PubMed ID: 25607702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-life practice study of the clinical outcome and cost-effectiveness of photodynamic therapy using methyl aminolevulinate (MAL-PDT) in the management of actinic keratosis and basal cell carcinoma.
    Annemans L; Caekelbergh K; Roelandts R; Boonen H; Leys C; Nikkels AF; van Den Haute V; van Quickenborne L; Verhaeghe E; Leroy B
    Eur J Dermatol; 2008; 18(5):539-46. PubMed ID: 18693157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Daylight methyl-aminolevulinate photodynamic therapy versus ingenol mebutate for the treatment of actinic keratoses: an intraindividual comparative analysis.
    Genovese G; Fai D; Fai C; Mavilia L; Mercuri SR
    Dermatol Ther; 2016 May; 29(3):191-6. PubMed ID: 26799440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-Effectiveness and Cost-Utility Analysis of Ingenol Mebutate Versus Diclofenac 3% and Imiquimod 5% in the Treatment of Actinic Keratosis in Spain.
    Elías I; Ortega-Joaquín N; de la Cueva P; Del Pozo LJ; Moreno-Ramírez D; Boada A; Aguilar M; Mirada A; Mosquera E; Gibbons C; Oyagüez I
    Actas Dermosifiliogr; 2016; 107(6):498-508. PubMed ID: 27130804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-efficacy analysis of 3% diclofenac sodium, ingenol mebutate, and 3.75% imiquimod in the treatment of actinic keratosis.
    Nisticò S; Del Duca E; Torchia V; Gliozzi M; Bottoni U; Muscoli C
    Int J Immunopathol Pharmacol; 2018; 32():2058738418757925. PubMed ID: 29442526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of topical interventions for the treatment of actinic keratosis.
    Koch EAT; Wessely A; Steeb T; Berking C; Heppt MV
    Expert Opin Drug Saf; 2021 Jul; 20(7):801-814. PubMed ID: 33834933
    [No Abstract]   [Full Text] [Related]  

  • 10. Ingenol mebutate: a new option for actinic keratosis treatment.
    Gras J
    Drugs Today (Barc); 2013 Jan; 49(1):15-22. PubMed ID: 23362492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cost-utility analysis of ingenol mebutate gel for the treatment of actinic keratosis: a Scottish perspective.
    Tolley K; Kemmett D; Thybo S; Nasr R; Smethurst H
    Eur J Health Econ; 2016 Apr; 17(3):287-304. PubMed ID: 25795391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-life Data on Patient Characteristics, Cost and Effectiveness of Field-directed Treatment for Actinic Keratoses: An Observational Study.
    van Rijsingen MC; Seubring I; Grutters JP; Maessen-Visch MB; Alkemade HA; van Doorn R; Groenewoud H; van de Kerkhof PC; van der Wilt GJ; Gerritsen MJ
    Acta Derm Venereol; 2016 Mar; 96(3):346-50. PubMed ID: 26280988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-utility of first-line actinic keratosis treatments in Finland.
    Soini EJ; Hallinen T; Sokka AL; Saarinen K
    Adv Ther; 2015 May; 32(5):455-76. PubMed ID: 26006101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential daylight photodynamic therapy and ingenol mebutate versus 2 sessions of daylight photodynamic therapy for the treatment of actinic keratosis: An observational, prospective, comparative study.
    Gracia-Cazaña T; Malinis AJG; Almagro-Sánchez M; Linares DP; Gilaberte Y
    Photodiagnosis Photodyn Ther; 2019 Sep; 27():34-38. PubMed ID: 31141728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized Trial of Four Treatment Approaches for Actinic Keratosis.
    Jansen MHE; Kessels JPHM; Nelemans PJ; Kouloubis N; Arits AHMM; van Pelt HPA; Quaedvlieg PJF; Essers BAB; Steijlen PM; Kelleners-Smeets NWJ; Mosterd K
    N Engl J Med; 2019 Mar; 380(10):935-946. PubMed ID: 30855743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized split-scalp study comparing calcipotriol-assisted methyl aminolaevulinate photodynamic therapy (MAL-PDT) with conventional MAL-PDT for the treatment of actinic keratosis.
    Torezan L; Grinblat B; Haedersdal M; Valente N; Festa-Neto C; Szeimies RM
    Br J Dermatol; 2018 Oct; 179(4):829-835. PubMed ID: 29476546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Field Therapy for Actinic Keratosis: A Structured Review of the Literature on Efficacy, Cost, and Adherence.
    Lampley N; Rigo R; Schlesinger T; Rossi AM
    Dermatol Surg; 2023 Feb; 49(2):124-129. PubMed ID: 36728061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PICATO (ingenol mebutate 0.015% and 0.05% gels): a novel treatment for actinic keratosis.
    Abramovits W; Oquendo M; Vincent KD; Gupta AK
    Skinmed; 2013; 11(2):111-5. PubMed ID: 23745230
    [No Abstract]   [Full Text] [Related]  

  • 19. Safety and tolerability of ingenol mebutate in the treatment of actinic keratosis.
    Berman B
    Expert Opin Drug Saf; 2015; 14(12):1969-78. PubMed ID: 26524598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacoeconomic evaluations in the treatment of actinic keratoses.
    Tolley K; Argenziano G; Calzavara-Pinton PG; Larsson T; Ryttig L
    Int J Immunopathol Pharmacol; 2017 Jun; 30(2):178-181. PubMed ID: 28580871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.